-
Admin
Dementia, yes, but this is not Alzheimer?s
Looking More Closely at Lewy Body Dementia University…
-
Admin
MIT-Novartis prototype produces 1,000 pills in 24 hours
Inventing A Machine That Spits Out Drugs In A…
-
-
Admin
Pipeline biosimilar for asthma meets primary endpoint in P2/3 study
In Brief Biosimilar News reports that Sorrento’s experimental anti-IgE biosimilar,…
-
Admin
Insights into “passive candidates” to fill HR pipelines
“The Big Hunt”?provides great?insights into HR recruiters’ cultivation of “passive…
Latest Posts
Categories
- Best Practices
- Change Management
- Clinical
- Clinical Trials
- Collaboration
- Communication
- Complexity
- Governance
- International Clinical Trials Day
- Leadership
- Marketing
- Medical Education
- MSL
- Patient-centered
- Pharma News
- PMOs
- Portfolio Management
- Program Management
- Project Management
- Project Management Salaries
- Project/Program/Portfolio Management
- Recruiting
- Salaries
- Uncategorized
Tags
3SixtyPharma Alzheimer's Anti-IgE anti-inflammatory anti-TNF anti-TNF-? B-cell Biosimilar clinical clinical research CNS Communication CT-P13 DEMENTIA FDA gastrointestinal genome GI Inflammation Inflectra infliximab interchangeability investigational JAK inhibitor KTE-C19 Lymphoma oncology patients Pharma Portfolio Management Program Management Project Management rare disease remote Remsima rheumatoid arthritis spondyloarthritis switching Theravance Biopharma virtual w webinar White House White House Office of Management and Budget White House OMB